"AIIMS Delhi starts screening of children for Covaxin trials"

7th June,2021

"AIIMS Delhi starts screening of children for Covaxin trials"

The screening of children aged 2 to 18 for a trial of Covaxin, India's first indigenously developed COVID-19 vaccine, began on June 7 at the AIIMS in New Delhi. At AIIMS Patna, a trial on children has already begun to assess if the Bharat Biotech vaccine is safe for them. Following the receipt of their screening report, participants would be given the vaccination.

A total of 525 healthy participants will participate in the study. The vaccine will be administered intramuscularly in two doses on days 0 and 28 of the experiment. “The screening of youngsters in preparation for the Covaxin study has begun. Participants will be administered the vaccination after their screening data are received, according to Dr. Sanjay Rai.On May 12, India's medicines regulator received authorization to launch a Phase 2/3 clinical study of Covaxin in children aged 2 to 18. Adults are being vaccinated with Covaxin as part of India's ongoing COVID-19 vaccination campaign. Even while COVID-19 has not yet assumed a major form among children, the government warned last week that if virus behaviour or epidemiological dynamics alter, the virus's influence could increase among them, and that preparations are being enhanced to deal with any such situation.NITI Aayog Member (Health) V.K. Paul said at a press conference that a national expert group has been formed to review COVID-19 infections in children and approach the pandemic in a renewed way to strengthen the nation's preparedness.

He claims that the committee has looked at indications that were not available four to five months ago.The child cohort is a large one. If it's between the ages of 12 and 18, I'm guessing it'll be around 13 to 14 crore people, which means we'll need roughly 25-26 crore dosages. “We can't have some individuals get it while others don't. As a result, when we strategize and make decisions based on how many doses of whatever vaccines are available, we will have to take this into account,” he said.

He also mentioned that Zydus Cadila's vaccine is being tested in youngsters.